Central Bank & Trust’s Xylem XYL Stock Holding History

Central Bank & Trust’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12	Closed	-$1.26K	–	429
2023 Q1	$1.26K	Buy	+12	New	+$1.25K	﹤0.01%	370

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Central Bank & Trust's XYL Position: Q2 2023 in Review

Central Bank & Trust sold out of Xylem (XYL) in Q2 2023, closing a stake of 12 shares — an estimated $1.26K sold.

Central Bank & Trust first reported a position in XYL in Q1 2023 and held it in 1 quarter. The position peaked at $1.26K in Q1 2023. 908 funds tracked by Wall St. Rank hold XYL as of Q2 2023.

Central Bank & Trust reported no remaining Xylem position as of Q2 2023 after selling out during the quarter.
Central Bank & Trust sold 12 Xylem shares in Q2 2023, an estimated $1.26K.
Central Bank & Trust first reported a position in Xylem in Q1 2023 and held it in 1 quarter.
Central Bank & Trust's Xylem position peaked at $1.26K in Q1 2023.
908 funds tracked by Wall St. Rank held Xylem as of Q2 2023.

Based on Central Bank & Trust's 13F filing for Q2 2023, filed 13 Jul 2023.